Cost-effectiveness of feedback-informed psychological treatment: Evidence from the IAPT-FIT trial.


Journal

Behaviour research and therapy
ISSN: 1873-622X
Titre abrégé: Behav Res Ther
Pays: England
ID NLM: 0372477

Informations de publication

Date de publication:
07 2021
Historique:
received: 08 08 2020
revised: 08 02 2021
accepted: 19 04 2021
pubmed: 5 5 2021
medline: 26 10 2021
entrez: 4 5 2021
Statut: ppublish

Résumé

Feedback-informed treatment (FIT) involves using computerized routine outcome monitoring technology to alert therapists to cases that are not responding well to psychotherapy, prompting them to identify and resolve obstacles to improvement. In this study, we present the first health economic evaluation of FIT, compared to usual care, to enable decision makers to judge whether this approach represents a good investment for health systems. This randomised controlled trial included 2233 patients clustered within 77 therapists who were randomly assigned to a FIT group (n = 1176) or a usual care control group (n = 1057). Treatment response was monitored using patient-reported depression (PHQ-9) and anxiety (GAD-7) measures. Therapists in the FIT group had access to a computerized algorithm that alerted them to cases that were "not on track", compared to normative clinical data. Health service costs included the cost of training therapists to use FIT and the cost of therapy sessions in each arm. The incremental cost-effectiveness of FIT was assessed relative to usual care, using multilevel modelling. FIT was associated with an increased probability of reliable symptomatic improvement by 8.09 percentage points (95% CI: 4.16%-12.03%) which was statistically significant. The incremental cost of FIT was £15.17 (95% CI: £6.95 to £37.29) per patient and was not statistically significant. The incremental cost-effectiveness ratio (ICER) per additional case of reliable improvement was £187.4 (95% CI: £126.7 to £501.5); this confidence interval shows that the relative cost-effectiveness is between FIT being a dominant strategy (i.e. more effective and also cost-saving) to FIT being more effective at a modest incremental cost to the health system. The FIT strategy increases the probability of reliable improvement in routine clinical practice and may be associated with a small (but uncertain) incremental cost. FIT is likely to be a cost-effective strategy for mental health services.

Sections du résumé

BACKGROUND
Feedback-informed treatment (FIT) involves using computerized routine outcome monitoring technology to alert therapists to cases that are not responding well to psychotherapy, prompting them to identify and resolve obstacles to improvement. In this study, we present the first health economic evaluation of FIT, compared to usual care, to enable decision makers to judge whether this approach represents a good investment for health systems.
METHODS
This randomised controlled trial included 2233 patients clustered within 77 therapists who were randomly assigned to a FIT group (n = 1176) or a usual care control group (n = 1057). Treatment response was monitored using patient-reported depression (PHQ-9) and anxiety (GAD-7) measures. Therapists in the FIT group had access to a computerized algorithm that alerted them to cases that were "not on track", compared to normative clinical data. Health service costs included the cost of training therapists to use FIT and the cost of therapy sessions in each arm. The incremental cost-effectiveness of FIT was assessed relative to usual care, using multilevel modelling.
RESULTS
FIT was associated with an increased probability of reliable symptomatic improvement by 8.09 percentage points (95% CI: 4.16%-12.03%) which was statistically significant. The incremental cost of FIT was £15.17 (95% CI: £6.95 to £37.29) per patient and was not statistically significant. The incremental cost-effectiveness ratio (ICER) per additional case of reliable improvement was £187.4 (95% CI: £126.7 to £501.5); this confidence interval shows that the relative cost-effectiveness is between FIT being a dominant strategy (i.e. more effective and also cost-saving) to FIT being more effective at a modest incremental cost to the health system.
CONCLUSIONS
The FIT strategy increases the probability of reliable improvement in routine clinical practice and may be associated with a small (but uncertain) incremental cost. FIT is likely to be a cost-effective strategy for mental health services.

Identifiants

pubmed: 33945983
pii: S0005-7967(21)00072-3
doi: 10.1016/j.brat.2021.103873
pii:
doi:

Banques de données

ISRCTN
['ISRCTN12459454']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103873

Informations de copyright

Copyright © 2021 Elsevier Ltd. All rights reserved.

Auteurs

Jaime Delgadillo (J)

Clinical Psychology Unit, Department of Psychology, University of Sheffield, United Kingdom. Electronic address: jaime.delgadillo@nhs.net.

Dean McMillan (D)

Department of Health Sciences and Hull York Medical School, University of York, United Kingdom.

Simon Gilbody (S)

Department of Health Sciences and Hull York Medical School, University of York, United Kingdom.

Kim de Jong (K)

Institute of Psychology, Leiden University, Netherlands.

Mike Lucock (M)

Centre for Applied Research in Health, University of Huddersfield, UK.

Wolfgang Lutz (W)

Department of Psychology, University of Trier, Germany.

Julian Rubel (J)

Department of Psychology, Justus-Liebig-University Giessen, Germany.

Elisa Aguirre (E)

North East London National Health Service (NHS) Foundation Trust, UK.

Shehzad Ali (S)

Department of Health Sciences and Hull York Medical School, University of York, United Kingdom; Department of Epidemiology and Biostatistics, Western University, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH